Enhanced osteogenic potential of mesenchymal stem cells from cortical bone: A comparative analysis

Joseph S. Fernandez-Moure, Bruna Corradetti, Paige Chan, Jeffrey L. Van Eps, Trevor Janecek, Pranela Rameshwar, Bradley K. Weiner, Ennio Tasciotti

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


Introduction: Mesenchymal stem cells (MSCs) hold great promise for regenerative therapies in the musculoskeletal system. Although MSCs from bone marrow (BM-MSCs) and adipose tissue (AD-MSCs) have been extensively characterized, there is still debate as to the ideal source of MSCs for tissue-engineering applications in bone repair. Methods: MSCs were isolated from cortical bone fragments (CBF-MSCs) obtained from patients undergoing laminectomy, selected by fluorescence-activated cell sorting analysis, and tested for their potential to undergo mesodermic differentiation. CBF-MSCs were then compared with BM-MSCs and AD-MSCs for their colony-forming unit capability and osteogenic potential in both normoxia and hypoxia. After 2 and 4 weeks in inducing media, differentiation was assessed qualitatively and quantitatively by the evaluation of alkaline phosphatase (ALP) expression and mineral deposition (Von Kossa staining). Transcriptional activity of osteoblastogenesis-associated genes (Alp, RUNX2, Spp1, and Bglap) was also analyzed. Results: The cortical fraction of the bone contains a subset of cells positive for MSC-associated markers and capable of tri-lineage differentiation. The hypoxic conditions were generally more effective in inducing osteogenesis for the three cell lines. However, at 2 and 4 weeks, greater calcium deposition and ALP expression were observed in both hypoxic and normoxic conditions in CBF-MSCs compared with AD- and BM-MSCs. These functional observations were further corroborated by gene expression analysis, which showed a significant upregulation of Bglap, Alp, and Spp1, with a 22.50 (±4.55)-, 46.56 (±7.4)-, 71.46 (±4.16)-fold increase compared with their uninduced counterparts. Conclusions: This novel population of MSCs retains a greater biosynthetic activity in vitro, which was found increased in hypoxic conditions. The present study demonstrates that quantitative differences between MSCs retrieved from bone marrow, adipose, and the cortical portion of the bone with respect to their osteogenic potential exist and suggests the cortical bone as suitable candidae to use for orthopedic tissue engineering and regenerative medicine.

Original languageEnglish (US)
Article number203
JournalStem Cell Research and Therapy
Issue number1
StatePublished - Oct 26 2015
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by the Cullen Trust for Health Care Foundation for stem cell plasticity studies (Project ID: 18130014) and the Brown Foundation (Project ID: 18130011) (to ET). We acknowledge David Haviland and the Flow Cytometry Core of Houston Methodist Research Institute for their excellent support and technical consultation.

Publisher Copyright:
© 2015 Fernandez-Moure et al.


  • Cortical bone
  • Hypoxia
  • Mesenchymal stem cells
  • Multipotent differentiation ability
  • Normoxia
  • Osteogenic potential


Dive into the research topics of 'Enhanced osteogenic potential of mesenchymal stem cells from cortical bone: A comparative analysis'. Together they form a unique fingerprint.

Cite this